Safety and effectiveness of lung volume reduction surgery for treatment of Chronic obstructive pulmonary disease

被引:0
|
作者
Barresi, P. [1 ]
Mondello, B. [1 ]
Barone, M. [1 ]
Pavia, R. [1 ]
机构
[1] Univ Studi Messina, Azienda Ospedaliera Univ G Martino, Dipartimento Sci Cardiovascol Toraciche, Cattedra UOC Chirurgia Torac, Messina, Italy
来源
GIORNALE DI CHIRURGIA | 2005年 / 26卷 / 8-9期
关键词
Lung volume reduction surgery; (LVRS); COPD; Pulmonary emphysema; Respiratory rehabilitation;
D O I
暂无
中图分类号
R61 [外科手术学];
学科分类号
摘要
Lung volume reduction surgery (LVRS) has been proposed and performed in order to decrease dyspnea and improve wordly life without major impairments in oxygen-dependent patients affected by serious chronic obstructive pulmonary disease (COPD) and severe dyspnea that doesn't suffer drastic alterations notwithstanding rehabilitation procedures tailored for the specific case. The purpose of LVRS is to optmize thoraco-pulmonary dynamics, considerably compromised in these patients, relaxing the serious expiratory restraint to air flow and improving the muscular respiratory functionality. In this work the Authors bring forth the physio-pathological foundations that justify the use of LVRS, also analyzing data brought by the international literature about surgery guidelines, short-term morbidity and mortality, clinical-functional effects and long-term survival. They also underline the need for careful evaluation research, aimed at getting a precise account of cardiorespiratory functional outcome, that will enable the positive accomplishement of the demanding and risky surgery, especially whenever the pathology has reached remarkable proportions or appears to be bilaterally localized. Only committing to painstaking analysis, setting and customization protocols, the latter especially addressing carefully chosen patients, can the surgeon rely on to achieve both short and long-term positive outcomes.
引用
收藏
页码:307 / 310
页数:4
相关论文
共 50 条
  • [41] Effectiveness and safety of acupuncture as an adjunctive therapy for chronic obstructive pulmonary disease: a randomised controlled trial
    Xu, Guixing
    Luo, Qin
    Sun, Mingsheng
    Huang, Liuyang
    Liu, Jiali
    Yang, Chunyan
    Huang, Qingsong
    Xiong, Chan
    Yang, Zuoqin
    Yang, Sha
    Zeng, Fang
    Liang, Fanrong
    BMC COMPLEMENTARY MEDICINE AND THERAPIES, 2024, 24 (01)
  • [42] Treatment of End-Stage Chronic Obstructive Pulmonary Disease
    Crabtree, Traves D.
    THORACIC SURGERY CLINICS, 2021, 31 (02) : 189 - 201
  • [43] The Prognostic Value of Residual Volume/Total Lung Capacity in Patients with Chronic Obstructive Pulmonary Disease
    Shin, Tae Rim
    Oh, Yeon-Mok
    Park, Joo Hun
    Lee, Keu Sung
    Oh, Sunghee
    Kang, Dae Ryoung
    Sheen, Seungsoo
    Seo, Joon Beom
    Yoo, Kwang Ha
    Lee, Ji-Hyun
    Kim, Tae-Hyung
    Lim, Seong Yong
    Yoon, Ho Il
    Rhee, Chin Kook
    Choe, Kang-Hyeon
    Lee, Jae Seung
    Lee, Sang-Do
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2015, 30 (10) : 1459 - 1465
  • [44] Lung Function Testing in Chronic Obstructive Pulmonary Disease
    Neder, J. Alberto
    de-Torres, Juan Pablo
    Milne, Kathryn M.
    O'Donnell, Denis E.
    CLINICS IN CHEST MEDICINE, 2020, 41 (03) : 347 - 366
  • [45] Current treatment in chronic obstructive pulmonary disease
    李嘉惠
    中国新药与临床杂志, 2008, 27 (12) : 940 - 940
  • [46] Formoterol for the Treatment of Chronic Obstructive Pulmonary Disease
    Tashkin, Donald P.
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2020, 15 : 3105 - 3122
  • [47] Surgical treatment of chronic obstructive pulmonary disease
    Payne, DK
    Markewitz, BA
    Owens, MW
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1999, 318 (02) : 89 - 95
  • [48] Costs of Treatment of Chronic Obstructive Pulmonary Disease
    Milewska, A.
    Rysiak, E.
    Zareba, I.
    Holownia, A.
    Mroz, R. M.
    RESPIROLOGY, 2016, 885 : 67 - 75
  • [49] Revefenacin for the treatment of chronic obstructive pulmonary disease
    Clark, Collin M.
    Jacobs, David M.
    Sethi, Sanjay
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2020, 14 (03) : 239 - 247
  • [50] Canakinumab for the treatment of chronic obstructive pulmonary disease
    Rogliani, Paola
    Calzetta, Luigino
    Ora, Josuel
    Matera, Maria Gabriella
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2015, 31 : 15 - 27